chr7-38795435-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B.
The NM_014396.4(VPS41):c.717+30G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0617 in 1,597,732 control chromosomes in the GnomAD database, including 3,378 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.063 ( 312 hom., cov: 32)
Exomes 𝑓: 0.062 ( 3066 hom. )
Consequence
VPS41
NM_014396.4 intron
NM_014396.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.96
Publications
12 publications found
Genes affected
VPS41 (HGNC:12713): (VPS41 subunit of HOPS complex) Vesicle mediated protein sorting plays an important role in segregation of intracellular molecules into distinct organelles. Genetic studies in yeast have identified more than 40 vacuolar protein sorting (VPS) genes involved in vesicle transport to vacuoles. This gene encodes the human ortholog of yeast Vps41 protein which is also conserved in Drosophila, tomato, and Arabidopsis. Expression studies in yeast and human indicate that this protein may be involved in the formation and fusion of transport vesicles from the Golgi. Several transcript variants encoding different isoforms have been described for this gene, however, the full-length nature of not all is known. [provided by RefSeq, Jul 2008]
VPS41 Gene-Disease associations (from GenCC):
- spinocerebellar ataxia, autosomal recessive 29Inheritance: Unknown, AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- autosomal recessive cerebellar ataxia-saccadic intrusion syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 7-38795435-C-T is Benign according to our data. Variant chr7-38795435-C-T is described in ClinVar as [Benign]. Clinvar id is 1181871.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0723 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS41 | NM_014396.4 | c.717+30G>A | intron_variant | Intron 9 of 28 | ENST00000310301.9 | NP_055211.2 | ||
VPS41 | NM_080631.4 | c.642+30G>A | intron_variant | Intron 8 of 27 | NP_542198.2 | |||
VPS41 | XR_007060008.1 | n.734+30G>A | intron_variant | Intron 9 of 28 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0625 AC: 9515AN: 152140Hom.: 312 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
9515
AN:
152140
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0531 AC: 12687AN: 238862 AF XY: 0.0528 show subpopulations
GnomAD2 exomes
AF:
AC:
12687
AN:
238862
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0617 AC: 89114AN: 1445474Hom.: 3066 Cov.: 30 AF XY: 0.0606 AC XY: 43520AN XY: 718294 show subpopulations
GnomAD4 exome
AF:
AC:
89114
AN:
1445474
Hom.:
Cov.:
30
AF XY:
AC XY:
43520
AN XY:
718294
show subpopulations
African (AFR)
AF:
AC:
2425
AN:
33016
American (AMR)
AF:
AC:
1599
AN:
43366
Ashkenazi Jewish (ASJ)
AF:
AC:
1707
AN:
25042
East Asian (EAS)
AF:
AC:
5
AN:
39424
South Asian (SAS)
AF:
AC:
2173
AN:
83708
European-Finnish (FIN)
AF:
AC:
3742
AN:
52786
Middle Eastern (MID)
AF:
AC:
425
AN:
5664
European-Non Finnish (NFE)
AF:
AC:
73516
AN:
1102768
Other (OTH)
AF:
AC:
3522
AN:
59700
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
3649
7298
10946
14595
18244
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2768
5536
8304
11072
13840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0625 AC: 9517AN: 152258Hom.: 312 Cov.: 32 AF XY: 0.0619 AC XY: 4611AN XY: 74450 show subpopulations
GnomAD4 genome
AF:
AC:
9517
AN:
152258
Hom.:
Cov.:
32
AF XY:
AC XY:
4611
AN XY:
74450
show subpopulations
African (AFR)
AF:
AC:
3097
AN:
41554
American (AMR)
AF:
AC:
679
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
259
AN:
3472
East Asian (EAS)
AF:
AC:
2
AN:
5180
South Asian (SAS)
AF:
AC:
128
AN:
4820
European-Finnish (FIN)
AF:
AC:
802
AN:
10618
Middle Eastern (MID)
AF:
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4335
AN:
68006
Other (OTH)
AF:
AC:
142
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
447
895
1342
1790
2237
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
62
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
May 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.